Literature DB >> 2949328

Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.

A V Schally, J I Paz-Bouza, J V Schlosser, T Karashima, L Debeljuk, B Gandle, M Sampson.   

Abstract

Possible protective effects of the agonist [D-Trp6]LH-RH (analog of luteinizing hormone-releasing hormone in which Gly-6 is replaced by D-tryptophan) and antagonist N-Ac-[D-Phe(pCI)1,2,D-Trp3,D-Arg6,D-Ala10]LH-RH against testicular damage caused by x-radiation were investigated in rats. Three months after being subjected to x-irradiation of the testes with 415 or 622 rads, control rats showed marked reduction in the weights of the testes and elevated levels of LH and follicle-stimulating hormone (FSH), indicating tubular damage. Histological studies demonstrated that, in testes of rats given 415 rads, most seminiferous tubules had only Sertoli cells and no germinal cells, and, in the group given 622 rads, the depression of spermatogenesis was even more marked. Rats pretreated for 50 days with LH-RH antagonist (1000 micrograms/kg of body weight per day) showed a complete recovery of testicular weights and spermatogenesis 3 months after 415 rads and showed partial recovery after 622 rads, and LH and FSH levels returned to normal in both of these groups. Thus, pretreatment of rats with LH-RH antagonist, by reversibly inhibiting gonadal function, protected the germinal cells of the testes against damaging effects of x-rays. Three experiments were also carried out in which the rats were pretreated for 1-2 months with long-acting microcapsules of the agonist [D-Trp6]LH-RH, liberating 25 micrograms of the agonist per day. Some rats were then subjected to gonadal irradiation with 415 or 622 rads and allowed a recovery period of 2-4 months. In spite of pretreatment with [D-Trp6]LH-RH, testicular weights were significantly lower and LH or FSH levels were elevated in the irradiated groups as compared with nonirradiated controls. The recovery of spermatogenesis was incomplete, and there was a decrease in the number of germinal cells after 415 rads and especially after 622 rads. On the basis of testicular weights, histology, and gonadotropin levels, it could be concluded that the agonist [D-Trp6]LH-RH did not protect the rat testes exposed to 622 rads and, at most, only partially protected against 415 rads. These results suggest that pretreatment with LH-RH antagonists and possibly agonists, might decrease the testicular damage caused by radiation and accelerate the recovery of reproductive functions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949328      PMCID: PMC304314          DOI: 10.1073/pnas.84.3.851

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  AET protection of reproductive capacity of irradiated mice.

Authors:  U H EHLING; D G DOHERTY
Journal:  Proc Soc Exp Biol Med       Date:  1962-07

Review 2.  Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective.

Authors:  M J Karten; J E Rivier
Journal:  Endocr Rev       Date:  1986-02       Impact factor: 19.871

3.  Particle-beam radiation therapy 1983: evaluation and recommendations.

Authors:  M P Richter; M M Kligerman
Journal:  Cancer Treat Rep       Date:  1984-01

Review 4.  Some principles of radiobiology: a selective review.

Authors:  F D Malkinson
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

5.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

Review 6.  LH-RH agonists and antagonists.

Authors:  A V Schally; D H Coy; A Arimura
Journal:  Int J Gynaecol Obstet       Date:  1980       Impact factor: 3.561

7.  Pituitary gonadotropin inhibition by a highly active analog of luteinizing hormone-releasing hormone.

Authors:  J Sandow; W Von Rechenberg; G Jerzabek; W Stoll
Journal:  Fertil Steril       Date:  1978-08       Impact factor: 7.329

8.  Promise of radiosensitizers and radioprotectors in the treatment of human cancer.

Authors:  T L Phillips; T H Wasserman
Journal:  Cancer Treat Rep       Date:  1984-01

9.  Effect of cytotoxic therapy on sexuality and gonadal function.

Authors:  R M Chapman
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

10.  Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH.

Authors:  A V Schally; T W Redding; A M Comaru-Schally
Journal:  Prostate       Date:  1983       Impact factor: 4.104

View more
  6 in total

1.  Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.

Authors:  B Jégou; J F Velez de la Calle; F Bauché
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.

Authors:  T Karashima; A Zalatnai; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Suppression of meiosis of male germ cells by an antagonist of luteinizing hormone-releasing hormone.

Authors:  B Szende; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-Tryptophan-6 luteinizing hormone releasing hormone.

Authors:  W Brennemann; K A Brensing; N Leipner; I Boldt; D Klingmüller
Journal:  Clin Investig       Date:  1994-11

5.  Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.

Authors:  L Bokser; B Szende; A V Schally
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

6.  Cryopreservation of testis tissues and in vitro spermatogenesis.

Authors:  Tetsuhiro Yokonishi; Takehiko Ogawa
Journal:  Reprod Med Biol       Date:  2015-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.